Navigation Links
New study indicates smallpox vaccination effective for decades
Date:12/23/2008

New York, December 1, 2008 Although naturally occurring smallpox was eradicated in 1977, there is concern that bioterrorists might obtain smallpox from a laboratory and release it into the population. Under such circumstances, the supply of smallpox vaccine may be insufficient for universal administration. In a study published in the December 2008 issue of The American Journal of Medicine, researchers found that lifetime protection is obtained from just one vaccination, even when that vaccination occurred as much as 88 years ago. They conclude that in the event of a smallpox bioterrorist attack, vaccinia smallpox vaccine should be used first on individuals who have not been vaccinated previously.

Examining 246 participants of the Baltimore Longitudinal Study of Aging, investigators from the National Institute on Aging and the National Institute of Allergy and Infectious Diseases, National Institutes of Health found permanent immunity was conferred by vaccination or by survival from an active smallpox infection. In the sample, 209 subjects were vaccinated one or more times 13 to 88 years prior to the study; an additional 18 had had childhood smallpox, and 29 with no history of vaccination or smallpox were included.

Although the vaccinia virus vaccine was used since the late 18th century, routine vaccination was discontinued more than 30 years ago in many countries. Most Americans under 35 have never been vaccinated and most over 35 have not received booster immunizations since the early 1970s. If a bioterrorist attack were to occur, it would be critical to know who already had effective immunity and would not need to be vaccinated, leaving another dose available for someone else.

Current recommendations relating to smallpox vaccination has been that people with repeated exposure to smallpox, for example travelers to endemic areas, should be revaccinated every five years. This study suggests that such reimmunizations may not be
'/>"/>

Contact: Pamela Poppalardo
ajmmedia@elsevier.com
212-633-3944
Elsevier Health Sciences
Source:Eurekalert

Page: 1 2

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Kline Study: Better Brushing Habits Boost European Oral Care Sales
4. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
5. NASA study will help stop stowaways to Mars
6. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
7. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
8. Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201
9. Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes
10. Quigley Corporation Releases Update on Quigley Pharmas Phase IIb Clinical Study of QR-333 in Diabetic Peripheral Neuropathy
11. Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...November 24 Shire plc (L...opharmaceutical company, today,announced that it h...y for,velaglucerase alfa, the company,s enzyme rep...of Type 1 Gaucher disease. This is the third marke...een submitted, with previous,submissions in the Un...
(Date:11/24/2009)...Y, Calif., Nov. 24 Genom...hat Randy Scott, Genomic Health,s Executive Chairm...Health Care Conference in New York City on Tuesday...ess the live and subsequently archived webcast of ...tion of Genomic Health,s website at http://invest...
(Date:11/24/2009)... Program Connects Customers with Partners Validate...A Genotek Products , Otta... a leading provider of products for biological sam...ay announced its new global partner program. The p...otek,s partner community and is designed to help p...
(Date:11/24/2009)...Nov. 24 Cell Therapeutic...ll present at the 21st Annual Piper Jaffray Health...mber 1-2, 2009, at the New York Palace Hotel. ,...00 a.m. Eastern Time in Holmes 1 (4th Floor). A li...ilable at www.celltherapeutics.com , and it will ...
Breaking Biology Technology:Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...oved by the Fda For Hypotrichosis of,Eyelashes , ... approved LATISSE(TM),(bimatoprost ophthalmic solu... of the eyelashes. Eyelash hypotrichosis is anothe...es. LATISSE(TM) is the first and only,FDA-approved...nence as,measured by increases in length, thicknes...
... Southern California (USC) have, for the first tim...) cells from rats. This breakthrough finding will ...mal models for the study of a range of human disea.... 26 issue of the journal Cell . , "This is a m...know that rats are much more closely related to hu...
...stem against deadly bacteria. However, how the ste... body is not yet known. To date, B. Pseudomallei,... to elude medics. It can remain hidden in the huma...e immune system. The bacteria can suddenly become ...g in the patient dying from blood poisoning. AMC p...
Other Biology Technology:MultiVu Video Feed: U.S Food and Drug Administration (Fda) Approves Latisse(TM) -- 2MultiVu Video Feed: U.S Food and Drug Administration (Fda) Approves Latisse(TM) -- 3USC researchers derive first embryonic stem cells from rats 2USC researchers derive first embryonic stem cells from rats 3
(Date:11/24/2009)...d flabby arteries from collapsing have been true l... no longer needed -- once the arteries are strengt...s had no choice but to leave them in place. , Pr...rtment of Biomedical Engineering has developed a n...s where they,re needed, then dissolves. , "Our n...
(Date:11/24/2009)...is a matter of debate. A high-profile study a few ...t of their carbon from trees and leaves, evidence ...aquatic ecosystems. , But new research from the ...to be true. Algae provide a much richer diet for f...published this week in the Proceedings of the Nat...
(Date:11/23/2009)...er 23, 2009 Applied mathematicians dissected the ... ), a characteristic long leaf with a saddle-like ...e edges. The simple cause of the lily,s fan-like s...ng differential growthwas revealed by using an equ... Haiyi Liang, a postdoctoral student at Harvard,s...
Breaking Biology News(10 mins):A coating for life 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3The cause behind the characteristic shape of a long leaf revealed 2Lexington International LLC Receives 2009 U S Presidents E Award Recognizing its Export Achievements 6381 1Lexington International LLC Receives 2009 U S Presidents E Award Recognizing its Export Achievements 6381 2Lexington International LLC Receives 2009 U S Presidents E Award Recognizing its Export Achievements 6381 3Zydena is Efficacious in Once Daily Dosing for Erectile Dysfunction Positive BPH Results 6378 1Zydena is Efficacious in Once Daily Dosing for Erectile Dysfunction Positive BPH Results 6378 2Zydena is Efficacious in Once Daily Dosing for Erectile Dysfunction Positive BPH Results 6378 3Drug for erectile dysfunction improves heart function in young heart disease patients 61624 1
...d gene therapy in two separate studies to renew br...and rats with a drug-induced form of Parkinson,s d...ientific publications Brain and The Journal of Neu...alt Parkinson,s disease at its onset and another s... occur when treating the disease in its later stag...
...y in St. Louis has proposed that evolution is the ...ment rather than physical processes, such as plate...iversity assistant professor of geomicrobiology in...in Arts & Sciences, studying Cyanobacteria ?ba...o produce oxygen and biomass ?has concluded that t...
...arolinska Institutet announced today that they hav...prove healthcare by accelerating the translation o...gnosis, prognosis, and treatment. , During the ne...s and measurement of gene expression in patients w...hritis, asthma and dyslexia. These diseases affect...
Other Biology News:Gene therapy for Parkinson's disease moves forward in animals 2Gene therapy for Parkinson's disease moves forward in animals 3Gene therapy for Parkinson's disease moves forward in animals 4Family trees of ancient bacteria reveal evolutionary moves 2Family trees of ancient bacteria reveal evolutionary moves 3Affymetrix and the Karolinska Institutet Announce Translational Medicine Strategic Alliance 2Affymetrix and the Karolinska Institutet Announce Translational Medicine Strategic Alliance 3
Mouse Anti-Human Troponin I Monoclonal Antibody, Unconjugated, Clone 22B11 from Santa Cruz Biotechnology, Inc.
... freezers , Ultima II Series ,Developed ...represents the finest, most enhanced ultra-low fre...ood bank configurations, each Ultima II freezer in...system with built-in voltage boost and surge suppr...
Perfusion Pressure Kit - 8 channel from AutoMate Scientific, Inc
BspT107 I (HgiC I, Ban I) from Takara Mirus Bio
Biology Products: